[Clinico-pharmacologic aspects of using riboflavin and riboflavin coenzymes (review of the literature)].
D000818:Animals; D002318:Cardiovascular Diseases / Q000188:drug therapy; D003141:Communicable Diseases / Q000188:drug therapy; D005128:Eye Diseases / Q000188:drug therapy; D005260:Female; D005486:Flavin Mononucleotide / Q000627:therapeutic use*; D005182:Flavin-Adenine Dinucleotide / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D006931:Hyperbaric Oxygenation / Q000009:adverse effects; D009751:Nutritional Requirements; D011183:Postoperative Complications / Q000188:drug therapy; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D012213:Rheumatic Fever / Q000188:drug therapy; D012256:Riboflavin / Q000627:therapeutic use*; D012257:Riboflavin Deficiency / Q000175:diagnosis; D012871:Skin Diseases / Q000188:drug therapy; D013272:Stomach Diseases / Q000188:drug therapy
D005182:Flavin-Adenine Dinucleotide; D005486:Flavin Mononucleotide; D012256:Riboflavin
Kliniko-farmakologicheskie aspekty primeneniia riboflavina i riboflavinovykh kofermentov (obzor literatury).